Sugi Predict

Sugi Predict / Compounds / SCHEMBL248746

SCHEMBL248746

SCHEMBL248746

CC(C)(C)OC(=O)C1CCCN1

nearest known ligand 0.45

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ NOS2 P35228 2/20 0.39
▸ NOS3 P29474 1/20 0.39
▸ NOS1 P29475 1/20 0.39
▸ DPP4 P27487 6/20 0.39
▸ DPP8 Q6V1X1 4/20 0.39
▸ DPP9 Q86TI2 4/20 0.39
▸ DPP7 Q9UHL4 2/20 0.39
▸ FAP Q12884 1/20 0.39
▸ SCN9A Q15858 2/20 0.39
▸ SCN3A Q9NY46 1/20 0.39
▸ SCN5A Q14524 1/20 0.39
▸ PRCP P42785 1/20 0.38
▸ SCN4A P35499 1/20 0.36
▸ GLI1 P08151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL248747 1.00 NOS2 (0.39) NOS2NOS3NOS1DPP4DPP8
SCHEMBL40093 1.00 NOS2 (0.39) NOS2NOS3NOS1DPP4DPP8
Bromide SCHEMBL27517782 0.98 NOS2 (0.38) NOS2NOS3NOS1DPP4DPP8
Hydrochloric Acid SCHEMBL596114 0.98 NOS2 (0.38) NOS2NOS3NOS1DPP4DPP8
Hydrochloric Acid SCHEMBL661790 0.98 NOS2 (0.38) NOS2NOS3NOS1DPP4DPP8
Hydrochloric Acid SCHEMBL661789 0.98 NOS2 (0.38) NOS2NOS3NOS1DPP4DPP8
SCHEMBL2804278 0.95 SCN9A (0.39) NOS2NOS3NOS1DPP4DPP8
Oxalic Acid SCHEMBL9353931 0.95 DPP4 (0.40) NOS2NOS3NOS1DPP4DPP8
SCHEMBL7384758 0.95 SCN9A (0.37) NOS2NOS3NOS1DPP4DPP8
SCHEMBL7384762 0.95 SCN9A (0.37) NOS2NOS3NOS1DPP4DPP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 553 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119470406-A Phthalic dicarboxaldehyde disinfectant concentration detection test paper and preparation method thereof 山东新华莎罗雅生物技术有限公司 2025-02-18 — — CN claimed
CN-112010822-B Method for preparing chiral gamma-amino alcohol and chiral alpha-allyl alcohol by one-pot method 南方科技大学 2022-11-18 — — CN claimed
CN-110339351-A The stabilizer that a kind of preparation method of veterinary rabies inactivated vaccine and the vaccine include 武汉科前生物股份有限公司 2019-10-18 — — CN claimed
US-20260092045-A1 SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS WILMINGTON TRUST, NATIONAL ASSOCIATION 2026-04-02 — — US disclosed
US-12583839-B2 PD-L1 antagonist compound ADLAI NORTYE BIOPHARMA CO., LTD. (CN) 2026-03-24 — — US disclosed
US-20250282792-A1 GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS RELATING THERETO NEUROCRINE BIOSCIENCES, INC. 2025-09-11 — — US disclosed
CN-120202206-A Cyclic benzimidazole derivatives as cGAS inhibitors 勃林格殷格翰国际有限公司 2025-06-24 — — CN disclosed
EP-4524133-A2 SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS Biocryst Pharmaceuticals, Inc. (US) 2025-03-19 — — EP disclosed
EP-4505875-A1 METHOD FOR CONTROLLING PARASITIC PLANTS AJINOMOTO CO., INC. (JP) 2025-02-12 — — EP disclosed
US-20250031699-A1 Method for Controlling Parasitic Plants AJINOMOTO CO., INC. (JP) 2025-01-30 — — US disclosed
CN-119301127-A 6-Oxo-decahydro pyrrolo [1,2-a ] [1,5] diazocine and 6-oxo-decahydro-4H-pyrrolo [2,1-d ] [1,5] thiaazacine derivatives as modulators of STAT3 and STAT6 for the treatment of cancer and inflammatory conditions 瑞克鲁迪克斯制药股份有限公司 2025-01-10 — — CN disclosed
US-4156786-A Amino acid derivatives E. R. SQUIBB & SONS, INC. (US) 1979-05-29 — — US disclosed
US-4154840-A Antihypertensive pipecolic acid derivatives E. R. SQUIBB & SONS, INC. (US) 1979-05-15 — — US disclosed
US-4154960-A Amino acid derivatives E. R. SQUIBB & SONS, INC. (US) 1979-05-15 — — US disclosed
US-4154946-A Amino mercapto substituted acylamino acids E. R. SQUIBB & SONS, INC. (US) 1979-05-15 — — US disclosed
US-4146611-A HYPOTENSIVE AGENTS E. R. SQUIBB & SONS, INC. (US) 1979-03-27 — — US disclosed
US-4129571-A Amino acid derivatives E. R. SQUIBB & SONS, INC. (US) 1978-12-12 — — US disclosed
US-4113715-A Amino acid derivatives E. R. SQUIBB & SONS, INC. (US) 1978-09-12 — — US disclosed
US-4105776-A ANGIOTENSIN CONVERTING ENZYME INHIBITORS, HYPOTENSIVE AGENTS E. R. SQUIBB & SONS, INC. (US) 1978-08-08 — — US disclosed
US-3947575-A Peptides as argiotensin converting enzyme inhibitors E. R. SQUIBB & SONS, INC. (US) 1976-03-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250282792-A1 GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS RELATING THERETO GNRHR, GHRHR, LHCGR NOS2 2654/4885NOS3 1555/4885NOS1 2456/4885
US-20260092045-A1 SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS TFPI, F3, BTK NOS2 1998/4885NOS3 1862/4885NOS1 2090/4885
US-20250031699-A1 Method for Controlling Parasitic Plants PTMS, DAO, GNMT NOS2 1527/4885NOS3 1117/4885NOS1 1511/4885
US-12583839-B2 PD-L1 antagonist compound CD274, PDCD1LG2, PDCD1 NOS2 1674/4885NOS3 1175/4885NOS1 667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.